Johnson & Johnson
All weather stocks: Two more names to ride out this rough market
There are two more stocks to consider for riding out the stock market storm of 2025. One sits atop a mountain of trash and the other atop a pile of cash. These are part of our new stock lists at CNBC Pro, which we launched with the All Weather Stock List near the end of […]
Read More
Kenvue settles proxy fight with activist Starboard, adding three directors to its board
Kenvue settled its proxy fight with activist Starboard Value, adding three new directors to its board. Starboard’s Jeff Smith will join the board of the Johnson & Johnson spinoff, along with Sarah Hofstetter, president of Profitero, an eCommerce performance analytics platform, and Erica Mann, former head of pharmaceutical company Bayer’s consumer health division. “Sarah’s brand […]
Read More
People who are truly content with life do these 10 little things every day: Ivy League-trained happiness expert
When life gets complicated, our instincts often lead us down the wrong path. We isolate ourselves when community could heal us, or we dream of endless free time when a new challenge could fulfill us. I’ve spent 15 years studying happiness, and I’ve had the opportunity to speak with thousands of people across all walks […]
Read More
An all weather investment that’s consistently positive for those tired of the market roller coaster
The first member of the CNBC Pro All Weather Stock list is a surprisingly resilient exchange-trade fund that offers high dividend income to boot. The timing is right for this list in particular because of the precarious set-up of the stock market so far in 2025. We’ll be adding to it periodically as the year […]
Read More
A complete guide to value investing — how Warren Buffett made his money
Warren Buffett has long been a proponent of value investing — and those principles have helped him amass a personal fortune of around $150 billion . It’s an investing approach that means taking the long view, holding your nerve and avoiding risky behavior — philosophies Buffett learned from economist Benjamin Graham’s 1949 book, “The Intelligent […]
Read More
Bristol Myers’ stock decline in response to weak guidance is a gift to investors
Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares lower. Jim Cramer’s faith in the drugmaker is unshaken. Revenue in the fourth quarter rose 8% year over year to $12.34 billion, well ahead of the $11.57 billion consensus, according to analysts’ estimates compiled by LSEG. Adjusted earnings per […]
Read More
Stocks making the biggest midday moves: Netflix, Johnson & Johnson, Oracle, Ford and more
Check out the companies making headlines in midday trading. Netflix — The streaming giant soared nearly 12% to an all-time high on the heels of better-than-expected results in the fourth quarter. Netflix reported earnings per share of $4.27 on revenue of $10.25 billion. Analysts polled by LSEG forecast $4.20 per share and $10.11 billion in […]
Read More
Stocks making the biggest moves premarket: Netflix, United Airlines, Procter & Gamble, Oracle and more
Check out the companies making headlines before the bell. Netflix — Shares popped more than 15% after the company announced a top- and bottom-line beat on Tuesday night. The streaming service earned $4.27 per share on $10.25 billion in revenue for the fourth quarter. Analysts surveyed by LSEG had expected earnings of $4.20 per share […]
Read More
S&P 500 futures rise after Tuesday’s post-inaugural rally: Live updates
Traders work on the floor of the New York Stock Exchange on Jan. 15, 2025, in New York City. David Dee Delgado | Getty Images S&P 500 futures rose Tuesday night after the first trading session post Inauguration Day ended with strong gains. S&P 500 futures rose 0.20%, while Nasdaq 100 futures gained 0.47%. Dow […]
Read More
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) on Dec. 5th, 2023. NYSE Group A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New York City after spending nearly a […]
Read More